FLGC
Flora Growth Corp. [FLGC] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
FLGC Stock Summary
Top 10 Correlated ETFs
FLGC
Top 10 Correlated Stocks
FLGC
In the News
Late August Green: Top Penny Stocks for the Last Week of August
Welcome to the intriguing world of marijuana stocks, where we will look at the top prospects for the next week in August 2023. These emerging opportunities in the cannabis sector have caught the interest of investors looking for potential profits. By harnessing the power of technical indicators, astute traders can navigate the volatility of these stocks and uncover promising short-term trading possibilities.
Marijuana Penny Stocks on the Radar
As we enter the third week of August, investors interested in investigating the dynamic world of marijuana stocks will discover some exciting options. While established cannabis conglomerates continue to dominate the US cannabis industry, the penny stock sector is causing a stir. With the potential for large gains, these smaller players necessitate careful evaluation and risk management. Traders should brace themselves for wild volatility as well as potential losses.
Blazing Opportunities: Top Marijuana Stocks To Watch On End Of July
As the cannabis industry and top marijuana stocks continue to rise, 2023 is an excellent opportunity for investors and traders to enter the thriving world of cannabis companies. With new markets opening up, regulatory environments changing, and consumer demand increasing, the prospect of short-term rewards is enticing. However, trading well in this volatile sector necessitates a cautious approach, including utilizing technical indicators, applying appropriate risk management, and completing extensive research on industry catalysts.
Flora Growth to Announce 2022 Year End Results April 3, 2023, at 8:00 a.m. ET
FORT LAUDERDALE, Fla. & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, will host its 2022 year end earnings call via webcast on Monday, April 3, 2023 at 8:00 a.m. ET.
5 Hot Penny Stocks To Watch With Big News This Week
Penny stocks fueled by news catalysts this week. The post 5 Hot Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Flora Growth to Host 2022 Year End Review Webcast January 30, 2023
FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a leading outdoor grower, manufacturer and distributor of cannabis products and brands worldwide, will host a webcast highlighting operational milestones achieved in 2022 which will take place on Monday, January 30th, 2023 at 4:30 p.m. ET.
Flora Growth Corp. (FLGC) Q3 2022 Earnings Call Transcript
Flora Growth Corp. (NASDAQ:FLGC ) Q3 2022 Earnings Conference Call November 28, 2022 4:30 PM ET Company Participants Jessie Casner - Chief Marketing Officer Luis Merchan - President & CEO Elshad Garayev - CEO Jason Warnock - Chief Commercial Officer Conference Call Participants Jessie Casner Hello, everyone, and welcome to the Flora Growth Third Quarter 2022 Earnings Results Webcast. I'm Jessie Casner, Chief Marketing Officer at Florida Growth.
Flora Growth Sets Third Quarter 2022 Conference Call for November 28, 2022, at 4:30 P.M. ET
FORT LAUDERDALE, Fla. & TORONTO--( BUSINESS WIRE )--Flora Growth Corp. (NASDAQ: FLGC) (“Flora'' or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its third quarter 2022 earnings call via webcast on Monday, November 28 at 4:30 p.m. ET.
Flora Growth to Host Webcast Discussing M&A Activity and International Market Opportunities - Wednesday, October 26, 2022
FORT LAUDERDALE, Fla.
Flora Growth buys Franchise Global Health in all-stock cannabis deal in German market
Flora Growth Corp. FLGC, +3.65% said Monday it would issue up between 36.62 million and 43.53 million common shares to acquire Franchise Global Health Inc. FGH, +12.50% a multi-national medical cannabis and pharmaceutical operator with principal operations in Germany. Based on Flora Growth's share price of 53 cents on Friday, the deal is currently valued at up to $23.5 million in stock.
FLGC Financial details
FLGC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue per share | 0 | 0.05 | 4.09 | 0.88 | |
| Net income per share | 0 | -6.79 | -9.72 | -1.25 | |
| Operating cash flow per share | 0 | -4.01 | -9.4 | -0.38 | |
| Free cash flow per share | 0 | -4.12 | -11.21 | -0.41 | |
| Cash per share | 0 | 7.39 | 17.12 | 0.21 | |
| Book value per share | 0 | 7.79 | 35.11 | 1.35 | |
| Tangible book value per share | 0 | 7.22 | 21.45 | 0.36 | |
| Share holders equity per share | 0 | 7.79 | 35.11 | 1.35 | |
| Interest debt per share | 0 | 0.32 | 0.65 | 0.1 | |
| Market cap | 0 | 201.29M | 78.24M | 191.63M | |
| Enterprise value | 1.19M | 186.42M | 41.96M | 186.24M | |
| P/E ratio | 0 | -14.12 | -3.66 | -3.64 | |
| Price to sales ratio | 0 | 1.9K | 8.71 | 5.16 | |
| POCF ratio | 0 | -23.9 | -3.79 | -12.03 | |
| PFCF ratio | 0 | -23.26 | -3.18 | -11.12 | |
| P/B Ratio | 0 | 12.3 | 1.01 | 3.37 | |
| PTB ratio | 0 | 12.3 | 1.01 | 3.37 | |
| EV to sales | 0 | 1.76K | 4.67 | 5.01 | |
| Enterprise value over EBITDA | 0 | -15.25 | -2.21 | 31.45 | |
| EV to operating cash flow | 0 | -22.14 | -2.03 | -11.69 | |
| EV to free cash flow | 0 | -21.54 | -1.7 | -10.81 | |
| Earnings yield | 0 | -0.07 | -0.27 | -0.27 | |
| Free cash flow yield | 0 | -0.04 | -0.31 | -0.09 | |
| Debt to equity | -1.03 | 0.04 | 0.02 | 0.07 | |
| Debt to assets | 1.13 | 0.03 | 0.02 | 0.05 | |
| Net debt to EBITDA | 0 | 1.22 | 1.91 | -0.91 | |
| Current ratio | 0.21 | 6.43 | 7.84 | 1.79 | |
| Interest coverage | 0 | -411.2 | -225.61 | 58.8 | |
| Income quality | 0 | 0.59 | 0.97 | 0.3 | |
| Dividend Yield | 0 | 0 | 0.03 | 0 | |
| Payout ratio | 0 | 0 | -0.12 | 0 | |
| Sales general and administrative to revenue | 0 | 111.76 | 1.94 | 0.67 | |
| Research and developement to revenue | 0 | 0.74 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.48 | 0.06 | 0.35 | 0.51 | |
| Capex to operating cash flow | 0 | 0.03 | 0.19 | 0.08 | |
| Capex to revenue | 0 | -2.21 | -0.44 | -0.03 | |
| Capex to depreciation | 0 | -2.07 | -5.21 | -0.49 | |
| Stock based compensation to revenue | 0 | 46.24 | 0.15 | 0.09 | |
| Graham number | 0 | 34.48 | 87.63 | 6.17 | |
| ROIC | 0 | -0.71 | -0.24 | 0.05 | |
| Return on tangible assets | 0 | -0.78 | -0.38 | -1.33 | |
| Graham Net | 0 | 6.43 | 15.83 | -0.07 | |
| Working capital | -1.77M | 14.89M | 41.82M | 13.71M | |
| Tangible asset value | -1.87M | 15.16M | 47.15M | 14.94M | |
| Net current asset value | -2.02M | 14.43M | 39.41M | 6.58M | |
| Invested capital | -1.03 | 0.04 | 0.02 | 0.07 | |
| Average receivables | 0 | 667.74K | 3.41M | 8.07M | |
| Average payables | 0 | 904.5K | 3.72M | 6.69M | |
| Average inventory | 0 | 270K | 1.79M | 6.56M | |
| Days sales outstanding | 0 | 4.21K | 227.49 | 103.61 | |
| Days payables outstanding | 0 | 18.87K | 313.38 | 124.27 | |
| Days of inventory on hand | 0 | 5.63K | 168.72 | 161.82 | |
| Receivables turnover | 0 | 0.09 | 1.6 | 3.52 | |
| Payables turnover | 0 | 0.02 | 1.16 | 2.94 | |
| Inventory turnover | 0 | 0.06 | 2.16 | 2.26 | |
| ROE | 0 | -0.87 | -0.28 | -0.93 | |
| Capex per share | 0 | -0.11 | -1.81 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.14 | 0.14 | 0.27 | 0.15 | 3.19 | |
| Net income per share | -0.59 | -0.1 | -0.3 | -0.03 | -6.62 | |
| Operating cash flow per share | -0.05 | -0.04 | -0.05 | -0.03 | -0.51 | |
| Free cash flow per share | -0.06 | -0.05 | -0.06 | -0.03 | -0.53 | |
| Cash per share | 0.14 | 0.08 | 0.21 | 0.04 | 0.26 | |
| Book value per share | 0.86 | 0.71 | 1.35 | 0.41 | 1.63 | |
| Tangible book value per share | 0.28 | 0.17 | 0.36 | 0.1 | 0.67 | |
| Share holders equity per share | 0.86 | 0.71 | 1.35 | 0.41 | 1.63 | |
| Interest debt per share | 0.3 | 0.04 | 0.88 | 0.03 | 0.51 | |
| Market cap | 891.91M | 1.08B | 191.63M | 781.26M | 16.01M | |
| Enterprise value | 885.35M | 1.08B | 186.24M | 779.95M | 17.6M | |
| P/E ratio | -5.17 | -36.75 | -3.82 | -50.02 | -0.09 | |
| Price to sales ratio | 89.45 | 100.49 | 16.68 | 38.86 | 0.75 | |
| POCF ratio | -227.41 | -323.01 | -91.12 | -180.68 | -4.63 | |
| PFCF ratio | -200.11 | -302.59 | -78.25 | -176.52 | -4.51 | |
| P/B Ratio | 14.21 | 19.85 | 3.37 | 14.45 | 1.46 | |
| PTB ratio | 14.21 | 19.85 | 3.37 | 14.45 | 1.46 | |
| EV to sales | 88.79 | 100.25 | 16.21 | 38.79 | 0.82 | |
| Enterprise value over EBITDA | -153.18 | -318.15 | 8.35 | -370.34 | -4.23 | |
| EV to operating cash flow | -225.74 | -322.24 | -88.56 | -180.38 | -5.09 | |
| EV to free cash flow | -198.64 | -301.87 | -76.05 | -176.22 | -4.96 | |
| Earnings yield | -0.05 | -0.01 | -0.07 | 0 | -2.78 | |
| Free cash flow yield | 0 | 0 | -0.01 | -0.01 | -0.22 | |
| Debt to equity | 0.06 | 0.06 | 0.07 | 0.07 | 0.31 | |
| Debt to assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.11 | |
| Net debt to EBITDA | 1.13 | 0.76 | -0.24 | 0.63 | -0.38 | |
| Current ratio | 3.18 | 2.64 | 1.79 | 1.8 | 1.25 | |
| Interest coverage | -0.39 | -58.36 | 0.68 | -132.52 | -1.43K | |
| Income quality | 0.16 | 0.45 | 0.17 | 1.11 | 0.08 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.63 | 0.5 | 0.6 | 0.28 | 0.26 | |
| Research and developement to revenue | 0.02 | 0.02 | -0.01 | 0 | 0 | |
| Intangibles to total assets | 0.53 | 0.57 | 0.51 | 0.53 | 0.19 | |
| Capex to operating cash flow | 0.14 | 0.07 | 0.16 | 0.02 | 0.03 | |
| Capex to revenue | -0.05 | -0.02 | -0.03 | -0.01 | 0 | |
| Capex to depreciation | -0.43 | -0.23 | 5.09 | -0.11 | -0.1 | |
| Stock based compensation to revenue | 0.13 | 0.01 | 0.02 | 0.03 | 0.02 | |
| Graham number | 3.37 | 1.24 | 3.01 | 0.52 | 15.57 | |
| ROIC | -0.17 | -0.07 | 0.31 | -0.05 | -2.36 | |
| Return on tangible assets | -1.17 | -0.23 | -0.32 | -0.11 | -1.8 | |
| Graham Net | 0.03 | -0.06 | -0.07 | -0.04 | -1.18 | |
| Working capital | 18.61M | 14.23M | 13.71M | 12.38M | 4.44M | |
| Tangible asset value | 20.37M | 12.66M | 14.94M | 12.77M | 4.51M | |
| Net current asset value | 10.56M | 3.94M | 6.58M | 4.45M | 2.01M | |
| Invested capital | 0.06 | 0.06 | 0.07 | 0.07 | 0.31 | |
| Average receivables | 0 | 5M | 7.6M | 10.49M | 9.33M | |
| Average payables | 0 | 7.48M | 7.65M | 7.04M | 6.47M | |
| Average inventory | 0 | 9.84M | 10.23M | 10.2M | 9.5M | |
| Days sales outstanding | 48.33 | 38.85 | 82.65 | 46.7 | 34.51 | |
| Days payables outstanding | 109.28 | 117.42 | 81.16 | 38.89 | 34.03 | |
| Days of inventory on hand | 137.46 | 161.1 | 105.68 | 63.43 | 44.66 | |
| Receivables turnover | 1.86 | 2.32 | 1.09 | 1.93 | 2.61 | |
| Payables turnover | 0.82 | 0.77 | 1.11 | 2.31 | 2.64 | |
| Inventory turnover | 0.65 | 0.56 | 0.85 | 1.42 | 2.02 | |
| ROE | -0.69 | -0.14 | -0.22 | -0.07 | -4.07 | |
| Capex per share | -0.01 | 0 | -0.01 | 0 | -0.01 |
FLGC Frequently Asked Questions
What is Flora Growth Corp. stock symbol ?
Flora Growth Corp. is a CA stock , located in Toronto of On and trading under the symbol FLGC
Is Flora Growth Corp. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $340. The lowest prediction is $340 and the highest is $340
What is FLGC stock prediction ?
What is Flora Growth Corp. stock quote today ?
Flora Growth Corp. stock price is $1.155 today.
Is Flora Growth Corp. stock public?
Yes, Flora Growth Corp. is a publicly traded company.
Company Profile
- Volume Average 148.78K
- Market Capitalization 7.54M
- Employee 337
- CEO Mr. Clifford A. Starke
- Headquarters Toronto,ON,CA
- IPO Date 2021-05-11
-
Website
https://www.floragrowth.com 
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.
